Treatment of extensive stage small cell lung cancerKELLY, Karen.Cancer treatment and research. 2001, Vol 105, pp 253-276, issn 0927-3042Article

Metacognition of Emotional Face RecognitionKELLY, Karen J; METCALFE, Janet.Emotion (Washington, D.C.). 2011, Vol 11, Num 4, pp 896-906, issn 1528-3542, 11 p.Article

Southwest Oncology Group S0802: A Randomized, Phase II Trial of Weekly Topotecan With and Without Ziv-Aflibercept in Patients With Platinum-Treated Small-Cell Lung CancerALLEN, Jeffrey W; MOON, James; REDMAN, Mary et al.Journal of clinical oncology. 2014, Vol 32, Num 23, pp 2463-2470, issn 0732-183X, 8 p.Article

Increased EGFR Gene Copy Number Detected by Fluorescent In Situ Hybridization Predicts Outcome in Non-Small-Cell Lung Cancer Patients Treated With Cetuximab and ChemotherapyHIRSCH, Fred R; HERBST, Roy S; OLSEN, Christine et al.Journal of clinical oncology. 2008, Vol 26, Num 20, pp 3351-3357, issn 0732-183X, 7 p.Article

ACCO: ASCO core curriculum outlineMUSS, Hyman B; VON ROENN, Jamie; MITCHELL, Beverly S et al.Journal of clinical oncology. 2005, Vol 23, Num 9, pp 2049-2077, issn 0732-183X, 29 p.Article

Efficacy of Gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic Patients with non-small cell lung Cancer a randomized trialKRIS, Mark G; NATALE, Ronald B; ALBAIN, Kathy S et al.JAMA, the journal of the American Medical Association. 2003, Vol 290, Num 16, pp 2149-2158, issn 0098-7484, 10 p.Article

Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): A California Cancer Registry analysisLARA, Matthew S; BRUNSON, Ann; WUN, Ted et al.Lung cancer. 2014, Vol 85, Num 2, pp 264-269, issn 0169-5002, 6 p.Article

N-Glycan Profiling of Dried Blood SpotsRENEE RUHAAK, L; MIYAMOTO, Suzanne; KELLY, Karen et al.Analytical chemistry (Washington). 2012, Vol 84, Num 1, pp 396-402, issn 0003-2700, 7 p.Article

Randomized Phase II trial of Sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): Carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxelEDELMAN, Martin J; CLARK, Joseph I; CHANSKY, Kari et al.Clinical cancer research. 2004, Vol 10, Num 15, pp 5022-5026, issn 1078-0432, 5 p.Article

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a southwest oncology group trialKELLY, Karen; CROWLEY, John; ISRAEL, Valerie K et al.Journal of clinical oncology. 2001, Vol 19, Num 13, pp 3210-3218, issn 0732-183XArticle

A Phase I/II trial of paclitaxel, carboplatin, and gemcitabine in untreated patients with advanced non-small cell lung cancerKELLY, Karen; MIKHAEEL-KAMEL, Nadine; ZHAOXING PAN et al.Clinical cancer research. 2000, Vol 6, Num 9, pp 3474-3479, issn 1078-0432Article

Pemetrexed Plus Gemcitabine As First-Line Chemotherapy for Patients With Peritoneal Mesothelioma : Final Report of a Phase II TrialSIMON, George R; VERSCHRAEGEN, Claire F; GILL, John et al.Journal of clinical oncology. 2008, Vol 26, Num 21, pp 3567-3572, issn 0732-183X, 6 p.Article

Treatment of advanced non-small-cell lung cancer in the elderly: Results of an International Expert PanelGRIDELLI, Cesare; AAPRO, Matti; SHEPHERD, Frances et al.Journal of clinical oncology. 2005, Vol 23, Num 13, pp 3125-3137, issn 0732-183X, 13 p.Article

Tracking the time to recovery after induced loudness reduction (L)ARIEH, Yoav; KELLY, Karen; MARKS, Lawrence E et al.The Journal of the Acoustical Society of America. 2005, Vol 117, Num 6, pp 3381-3384, issn 0001-4966, 4 p.Article

Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancerMONNERAT, Christian; LE CHEVALIER, Thierry; ETTINGER, David S et al.Clinical cancer research. 2004, Vol 10, Num 16, pp 5439-5446, issn 1078-0432, 8 p.Article

A prognostic model for advanced stage nonsmall cell lung cancer : Pooled analysis of north central cancer treatment group trialsMANDREKAR, Sumithra J; SCHILD, Steven E; ADJEI, Alex A et al.Cancer. 2006, Vol 107, Num 4, pp 781-792, issn 0008-543X, 12 p.Article

Efficacy and safety of gefitinib in chemonaive patients with advanced non-small cell lung cancer treated in an Expanded Access ProgramGOVINDAN, Ramaswamy; NATALE, Ronald; OCHS, Judith et al.Lung cancer. 2006, Vol 53, Num 3, pp 331-337, issn 0169-5002, 7 p.Article

Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancerFANUCCHI, Michael P; FOSSELLA, Frank V; AKERLEY, Wallace et al.Journal of clinical oncology. 2006, Vol 24, Num 31, pp 5025-5033, issn 0732-183X, 9 p.Article

Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancerTHIENELT, Christiane D; BUNN, Paul A; HANNA, Nasser et al.Journal of clinical oncology. 2005, Vol 23, Num 34, pp 8786-8793, issn 0732-183X, 8 p.Article

Gefitinib: Phase II and III results in advanced non-small cell lung cancerKELLY, Karen; AVERBUCH, Steven.Seminars in oncology. 2004, Vol 31, Num 1, pp 93-99, issn 0093-7754, 7 p., SUP1Article

Preclinical and clinical studies of docetaxel and exisulind in the treatment of human lung cancerBUNN, Paul A; CHAN, Daniel C; ALILA, Hector et al.Seminars in oncology. 2002, Vol 29, Num 1, pp 87-94, issn 0093-7754, SUP4Article

Comprehensive graphic-based display of clinical pathology laboratory dataHENRY, John Bernard; KELLY, Karen C.American journal of clinical pathology. 2003, Vol 119, Num 3, pp 330-336, issn 0002-9173, 7 p.Article

Novel approaches for the treatment of small cell lung cancerWAKELEE, Heather; KELLY, Karen.Hematology/oncology clinics of North America. 2004, Vol 18, Num 2, issn 0889-8588, x, 499-518 [21 p.]Article

Phylogenetic analysis of the succession of bacterial communities in the Great South Bay (Long Island)KELLY, Karen M; CHISTOSERDOV, Andrei Y.FEMS microbiology ecology. 2001, Vol 35, Num 1, pp 85-95, issn 0168-6496Article

Toward achieving optimal response : understanding and managing antidepressant side effectsKELLY, Karen; POSTERNAK, Michael; ALPERT, Jonathan E et al.Dialogues in clinical neuroscience. 2008, Vol 10, Num 4, pp 409-418, issn 1294-8322, 10 p.Article